Skip to main content

Bryn Mawr Trust Advisors, LLC

Position in RPRX — Royalty Pharma plc

CIK 1700481 PHILADELPHIA, PA

Position in RPRX

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$17,145,421
+$2,445,063 QoQ
Shares Held
305,786
-0.2% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
1.20%
of 13F equity value
Holder Rank
#115
of 646 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority Sole 7% Shared 0% None 93%

Common Shares in RPRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bryn Mawr Trust Advisors, LLC holds $17,795,145 across 4 Biotechnology names. RPRX ranks #1 (96.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
This page
305,786 $17,145,421

All Filings in RPRX

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $17,145,421 305,786
2026-03-31 $14,700,358 306,449
2025-12-31 $11,971,019 309,809
2025-09-30 $10,999,951 311,790
2025-06-30 $10,813,539 300,126
2025-03-31 $9,020,633 289,773
2024-12-31 $232,141 9,100
2024-09-30 $240,465 8,500